1180495-36-6Relevant articles and documents
MACROCYCLIC SERINE PROTEASE INHIBITORS
-
Paragraph 0231; 0232, (2017/05/31)
Provided herein are macrocyclic serine protease inhibitor compounds, for example, of Formula Ia or Ib, pharmaceutical compositions comprising the compounds, and processes of preparation thereof. Also provided are methods of their use for the treatment of an HCV infection in a host in need thereof.
COMPOUNDS
-
Page/Page column 39, (2010/08/08)
The present invention features compounds of Formula (I) and (Ia), pharmaceutical compositions and use in the treatment of viral disease: